Skip to main content
. 2017 Mar 8;102(7):2575–2583. doi: 10.1210/jc.2016-3529

Table 1.

Numbers of Thyroid Cancer Cases, Participants, Person-Years (P-yrs) of Follow-Up, RR, 95% CI, and Estimated Radiation-Associated Excess Cases

Dose (Gy)
Cases Participants P-yrs RRa 95% CI Excessb
Range Mean
0 0.000 142 46,439 1,865,957 1.00 0.0
0.001–0.004 0.002 24 9464 367,606 1.07 (0.7, 1.8) 0.4
0.005–0.02 0.009 30 13,796 587,614 1.21 (0.8, 1.9) 2.7
0.02–0.03 0.025 13 8055 345,748 0.87 (0.5, 1.6) 4.6
0.04–0.06 0.049 54 7204 315,014 2.01 (1.4, 2.8) 15.0
0.06–0.08 0.068 31 5825 256,456 1.40 (0.9, 2.1) 16.9
0.08–0.09 0.088 32 5535 242,247 1.78 (1.2, 2.7) 17.3
0.10–0.12 0.107 20 3220 136,943 2.51 (1.5, 4.1) 9.4
0.12–0.14 0.126 21 3537 149,525 2.63 (1.6, 4.2) 11.0
0.14–0.16 0.146 13 1778 73,824 3.76 (2.1, 6.8) 5.5
0.16–0.19 0.177 14 2741 113,582 2.41 (1.4, 4.3) 11.1
Total 394 107,594 4,454,516 93.8

Pooled data for doses <0.2 Gy.

a

RRs adjusted for study, sex, age, other study-specific factors, and chemotherapy exposure.

b

Estimated excess number of thyroid cancer cases above fitted background of nonexposed participants.